Page last updated: 2024-10-22

aprindine and Vertigo

aprindine has been researched along with Vertigo in 1 studies

Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sterz, H1

Trials

1 trial available for aprindine and Vertigo

ArticleYear
[Treatment of extrasystoles using a new oral anti-arrhythmic agent Aprindine].
    Acta medica Austriaca, 1974, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Aged; Aprindine; Cardiac Complexes, Premature; Clinical Trials as Topic; Drug Eva

1974